Kitae et al., 2021 - Google Patents
Asymptomatic postprandial hypotension in patients with diabetes: The KAMOGAWA‐HBP studyKitae et al., 2021
View PDF- Document ID
- 14107440006169700633
- Author
- Kitae A
- Ushigome E
- Hashimoto Y
- Majima S
- Senmaru T
- Osaka T
- Okada H
- Hamaguchi M
- Asano M
- Yamazaki M
- Fukui M
- Publication year
- Publication venue
- Journal of Diabetes Investigation
External Links
Snippet
Abstract Aims/Introduction Postprandial hypotension (PPH) refers to a decrease in systolic blood pressure by≥ 20 or to< 90 mmHg from baseline≥ 100 mmHg within 2 h of a meal. Previous studies have reported an association between diabetes and PPH; however, the …
- 206010012601 Diabetes mellitus 0 title abstract description 48
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/88—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/36—Computer-assisted acquisition of medical data, e.g. computerised clinical trials or questionnaires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
- G06F19/322—Management of patient personal data, e.g. patient records, conversion of records or privacy aspects
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Jun et al. | The association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetes | |
Chen et al. | Subclinical hypothyroidism is a risk factor for nephropathy and cardiovascular diseases in Type 2 diabetic patients | |
Raval et al. | Prevalence & determinants of depression in type 2 diabetes patients in a tertiary care centre | |
Ooteman et al. | Measuring craving: an attempt to connect subjective craving with cue reactivity | |
Sekiguchi et al. | Aldose reductase inhibitor ranirestat significantly improves nerve conduction velocity in diabetic polyneuropathy: A randomized double‐blind placebo‐controlled study in Japan | |
Ko et al. | Cardiovascular autonomic dysfunction predicts acute ischaemic stroke in patients with type 2 diabetes mellitus: a 7‐year follow‐up study | |
Baden et al. | Association of adiponectin with blood pressure in healthy people | |
Menant et al. | Pain and anxiety mediate the relationship between dizziness and falls in older people | |
Chao et al. | Binge eating and weight loss outcomes in individuals with type 2 diabetes: 4‐year results from the Look AHEAD Study | |
Liu et al. | Glycaemic control and its associated factors in Chinese adults with type 1 diabetes mellitus | |
Dybjer et al. | Incretin hormones, insulin, glucagon and advanced glycation end products in relation to cognitive function in older people with and without diabetes, a population‐based study | |
Jeffery et al. | Mood and its association with metabolic health in adolescents: a longitudinal study, EarlyBird 65 | |
Ohashi et al. | Diabetes management and daily functioning burden of non‐severe hypoglycemia in Japanese people treated with insulin | |
Christensen et al. | Prevalence of diabetic neuropathy in young adults with type 1 diabetes and the association with insulin pump therapy | |
Ida et al. | Relationship between sarcopenia and depression in older patients with diabetes: An investigation using the Japanese version of SARC‐F | |
Thomas et al. | Ethnicity, perceived discrimination, and vascular reactivity to phenylephrine | |
Sato et al. | Association of visit‐to‐visit glycemic variability with risk of cardiovascular diseases in high‐risk Japanese patients with type 2 diabetes: A subanalysis of the EMPATHY trial | |
Matsuoka et al. | Relationship between glycated hemoglobin level and duration of hypoglycemia in type 2 diabetes patients treated with sulfonylureas: a multicenter cross‐sectional study | |
Abu Sheikh et al. | Correlates of treatment satisfaction and well‐being among patients with type II diabetes | |
Kitae et al. | Asymptomatic postprandial hypotension in patients with diabetes: The KAMOGAWA‐HBP study | |
Logge et al. | Executive functioning moderates responses to appetitive cues: a study in severe alcohol use disorder and alcoholic liver disease | |
Candido | Which patients should be evaluated for blood glucose variability? | |
Davis et al. | Association between different hemoglobin A1c levels and clinical outcomes among elderly nursing home residents with type 2 diabetes mellitus | |
Masheb et al. | Sex differences and correlates of pain in patients with comorbid obesity and binge eating disorder | |
Buxton et al. | Lack of change in glucose metabolism in eszopiclone-treated primary insomnia patients |